VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
SK-08
Phase 1
Small molecule
C
Consun Pharmaceutical Group
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Chronic Kidney Disease (CKD)
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Chronic Kidney Disease (CKD)
Phase 1
Recruiting
Clinical
Trials by Indication
[1]
Unspecified
1 trial
A Study to Evaluate the Safety, Tolerability and PK of SK-08
Recruiting
·
C
Consun Pharmaceutical Group
·
Phase 1
·
NCT07021157
·
48 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for SK-08. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
SK-08 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for SK-08. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Consun Pharmaceutical Group company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
C
Consun Pharmaceutical Group
Related News